Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3801026, 10 pages
http://dx.doi.org/10.1155/2016/3801026
Review Article

Role of Autophagy and Apoptosis in the Postinfluenza Bacterial Pneumonia

1Department of Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, China
2State Key Laboratory of Oral Diseases, Sichuan University, Chengdu, Sichuan 610041, China

Received 14 January 2016; Revised 5 April 2016; Accepted 16 May 2016

Academic Editor: Kevin M. Coombs

Copyright © 2016 Zhen Qin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-M. Loo and M. Gale Jr., “Influenza: fatal immunity and the 1918 virus,” Nature, vol. 445, no. 7125, pp. 267–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. N. P. A. S. Johnson and J. Mueller, “Updating the accounts: global mortality of the 1918-1920 ‘Spanish’ influenza pandemic,” Bulletin of the History of Medicine, vol. 76, no. 1, pp. 105–115, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Palese and M. Shaw, “Orthomyxoviridae: the viruses and their replication,” in Fields Virology, D. M. Knipe and P. M. Howley, Eds., pp. 1647–1689, 4th edition, 2007. View at Google Scholar
  4. K. S. Li, Y. Guan, J. Wang et al., “Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia,” Nature, vol. 430, no. 6996, pp. 209–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Palese, “Influenza: old and new threats,” Nature Medicine, vol. 10, no. 12, pp. S82–S87, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. L. O'Brien, M. I. Walters, J. Sellman et al., “Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection,” Clinical Infectious Diseases, vol. 30, no. 5, pp. 784–789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Morens, J. K. Taubenberger, and A. S. Fauci, “Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness,” Journal of Infectious Diseases, vol. 198, no. 7, pp. 962–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Muscedere, M. Ofner, A. Kumar et al., “The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection,” Chest, vol. 144, no. 1, pp. 39–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Simonsen, “The global impact of influenza on morbidity and mortality,” Vaccine, vol. 17, no. 1, pp. S3–S10, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. K. P. Klugman, Y.-W. Chien, and S. A. Madhi, “Pneumococcal pneumonia and influenza: a deadly combination,” Vaccine, vol. 27, no. 3, pp. C9–C14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Madhi, K. P. Klugman, and Vaccine Trialist Group, “A role for Streptococcus pneumoniae in virus-associated pneumonia,” Nature Medicine, vol. 10, no. 8, pp. 811–813, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. C. J. Zavitz, C. M. T. Bauer, G. J. Gaschler et al., “Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza,” Journal of Immunology, vol. 184, no. 4, pp. 2001–2013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. E. J. Mifsud, A. C. Tan, K. R. Short, L. E. Brown, B. Y. Chua, and D. C. Jackson, “Reducing the impact of influenza-associated secondary pneumococcal infections,” Immunology and Cell Biology, vol. 94, pp. 101–108, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. Soper, “The pandemic in the Army camps,” Journal of the American Medical Association, vol. 71, pp. 1899–1909, 1918. View at Google Scholar
  15. L. H. Spooner, J. M. Scott, and E. H. Heath, “A bacteriologic study of the influenza epidemic at Camp Devens,” Journal of the American Medical Association, vol. 72, no. 3, pp. 155–159, 1919. View at Publisher · View at Google Scholar
  16. Prevention CDC, “Influenza,” CDC [homepage on the Internet], 2012, April 2016, http://www.cdc.gov/vaccines/pubs/pinkbook/flu.html.
  17. J. F. Brundage, “Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness,” Lancet Infectious Diseases, vol. 6, no. 5, pp. 303–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. McCullers and R. G. Webster, “A mouse model of dual infection with influenza virus and Streptococcus pneumoniae,” International Congress Series, vol. 1219, pp. 601–607, 2001. View at Publisher · View at Google Scholar
  19. J. A. McCullers and J. E. Rehg, “Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor,” Journal of Infectious Diseases, vol. 186, no. 3, pp. 341–350, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Seki, Y. Higashiyama, K. Tomono et al., “Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa,” Clinical and Experimental Immunology, vol. 137, no. 1, pp. 35–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. McCullers, J. L. McAuley, S. Browall, A. R. Iverson, K. L. Boyd, and B. H. Normark, “Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets,” Journal of Infectious Diseases, vol. 202, no. 8, pp. 1287–1295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. McNamee and A. G. Harmsen, “Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection,” Infection and Immunity, vol. 74, no. 12, pp. 6707–6721, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. T. Ellis, S. Davidson, S. Crotta, N. Branzk, V. Papayannopoulos, and A. Wack, “TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection,” EMBO Reports, vol. 16, no. 9, pp. 1203–1218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Berg, K. Hellwig, D. Stoll et al., “IVA induced IFNs facilitate development of secondary pneumococcal pneumonia in human lung tissue,” Pneumologie, vol. 69—A1, 2015. View at Publisher · View at Google Scholar
  25. J. A. McCullers, “Insights into the interaction between influenza virus and pneumococcus,” Clinical Microbiology Reviews, vol. 19, no. 3, pp. 571–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-C. Plotkowski, E. Puchelle, G. Beck, J. Jacquot, and C. Hannoun, “Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus,” American Review of Respiratory Disease, vol. 134, no. 5, pp. 1040–1044, 1986. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Mauad, L. A. Hajjar, G. D. Callegari et al., “Lung pathology in fatal novel human influenza A (H1N1) infection,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 1, pp. 72–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. L. Nickerson and G. J. Jakab, “Pulmonary antibacterial defenses during mild and severe influenza virus infection,” Infection and Immunity, vol. 58, no. 9, pp. 2809–2814, 1990. View at Google Scholar · View at Scopus
  29. J. Louie, C. Jean, T. H. Chen et al., “Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009,” Morbidity and Mortality Weekly Report, vol. 58, no. 38, pp. 1071–1074, 2009. View at Google Scholar
  30. W. Li, B. Moltedo, and T. M. Moran, “Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells,” Journal of Virology, vol. 86, no. 22, pp. 12304–12312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Lee, K. M. Robinson, K. J. McHugh et al., “Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 309, no. 2, pp. L158–L167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Shrestha, B. Foxman, S. Dawid et al., “Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae,” Journal of the Royal Society Interface, vol. 10, no. 86, article 0233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Sun and D. W. Metzger, “Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection,” Nature Medicine, vol. 14, no. 5, pp. 558–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. A. Pittet, L. Hall-Stoodley, M. R. Rutkowski, and A. G. Harmsen, “Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 4, pp. 450–460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Avadhanula, C. A. Rodriguez, J. P. De Vincenzo et al., “Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner,” Journal of Virology, vol. 80, no. 4, pp. 1629–1636, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Li, A. Ren, X. Wang et al., “Influenza viral neuraminidase primes bacterial coinfection through TGF-β—Mediated expression of host cell receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 1, pp. 238–243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Wang, T. Q. Le, N. Kurihara et al., “Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza,” Journal of Infectious Diseases, vol. 202, no. 7, pp. 991–1001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Chen, C. J. Wang, S. H. Lin, M. Zhang, S. Y. Li, and F. Xu, “Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia,” Cytokine, vol. 81, pp. 23–27, 2016. View at Publisher · View at Google Scholar
  39. K. F. van der Sluijs, L. J. R. Van Elden, M. Nijhuis et al., “IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection,” The Journal of Immunology, vol. 172, no. 12, pp. 7603–7609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. A. McCullers, “The co-pathogenesis of influenza viruses with bacteria in the lung,” Nature Reviews Microbiology, vol. 12, no. 4, pp. 252–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. K. R. Short, M. N. Habets, P. W. M. Hermans, and D. A. Diavatopoulos, “Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?” Future Microbiology, vol. 7, no. 5, pp. 609–624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. M. Smith and J. A. McCullers, “Secondary bacterial infections in influenza virus infection pathogenesis,” Current Topics in Microbiology and Immunology, vol. 385, pp. 327–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Yang and D. J. Klionsky, “Eaten alive: a history of macroautophagy,” Nature Cell Biology, vol. 12, no. 9, pp. 814–822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. D. J. Klionsky and S. D. Emr, “Autophagy as a regulated pathway of cellular degradation,” Science, vol. 290, no. 5497, pp. 1717–1721, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Zhou, X. Jiang, D. Liu et al., “Autophagy is involved in influenza A virus replication,” Autophagy, vol. 5, no. 3, pp. 321–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. H. Y. Law, D. C. W. Lee, and A. S. Y. Lau, “Role for autophagy in cellular response to influenza virus infection,” Hong Kong Medical Journal, vol. 20, supplement 6, pp. S20–S24, 2014. View at Google Scholar · View at Scopus
  47. B. Yordy and A. Iwasaki, “Autophagy in the control and pathogenesis of viral infection,” Current Opinion in Virology, vol. 1, no. 3, pp. 196–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Zhou, Association of influenza a virus with autophagy [Ph.D. dissertation], National Digital Library of China, 2007 (Chinese).
  49. Y. Sun, C. Li, Y. Shu et al., “Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection,” Science Signaling, vol. 5, no. 212, article ra16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Kroemer and B. Levine, “Autophagic cell death: the story of a misnomer,” Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 1004–1010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Ma, Q. Sun, R. Mi, and H. Zhang, “Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling,” Journal of Genetics and Genomics, vol. 38, no. 11, pp. 533–537, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Debnath, E. H. Baehrecke, and G. Kroemer, “Does autophagy contribute to cell death?” Autophagy, vol. 1, no. 2, pp. 66–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. R. A. Schwartzman and J. A. Cidlowski, “Apoptosis: the biochemistry and molecular biology of programmed cell death,” Endocrine Reviews, vol. 14, no. 2, pp. 133–151, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Takizawa, S. Matsukawa, Y. Higuchi, S. Nakamura, Y. Nakanishi, and R. Fukuda, “Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells,” Journal of General Virology, vol. 74, no. 11, pp. 2347–2355, 1993. View at Publisher · View at Google Scholar · View at Scopus
  57. V. S. Hinshaw, C. W. Olsen, N. Dybdahl-Sissoko, and D. Evans, “Apoptosis: a mechanism of cell killing by influenza A and B viruses,” Journal of Virology, vol. 68, no. 6, pp. 3667–3673, 1994. View at Google Scholar · View at Scopus
  58. I. Mori, T. Komatsu, K. Takeuchi, K. Nakakuki, M. Sudo, and Y. Kimura, “In vivo induction of apoptosis by influenza virus,” Journal of General Virology, vol. 76, no. 11, pp. 2869–2873, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. E. W. A. Brydon, S. J. Morris, and C. Sweet, “Role of apoptosis and cytokines in influenza virus morbidity,” FEMS Microbiology Reviews, vol. 29, no. 4, pp. 837–850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Julkunen, K. Melén, M. Nyqvist, J. Pirhonen, T. Sareneva, and S. Matikainen, “Inflammatory responses in influenza A virus infection,” Vaccine, vol. 19, no. 1, pp. S32–S37, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. I. C. Allen, M. A. Scull, C. B. Moore et al., “The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA,” Immunity, vol. 30, no. 4, pp. 556–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. P. G. Thomas, P. Dash, J. R. Aldridge Jr. et al., “The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1,” Immunity, vol. 30, no. 4, pp. 566–575, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. N. P. Restifo, “Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity,” Current Opinion in Immunology, vol. 12, no. 5, pp. 597–603, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. J.-M. Hament, J. L. L. Kimpen, A. Fleer, and T. F. W. Wolfs, “Respiratory viral infection predisposing for bacterial disease: a concise review,” FEMS Immunology and Medical Microbiology, vol. 26, no. 3-4, pp. 189–195, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. W. Chen, P. A. Calvo, D. Malide et al., “A novel influenza A virus mitochondrial protein that induces cell death,” Nature Medicine, vol. 7, no. 12, pp. 1306–1312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. J. L. McAuley, F. Hornung, K. L. Boyd et al., “Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia,” Cell Host and Microbe, vol. 2, no. 4, pp. 240–249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. J. L. McAuley, J. E. Chipuk, K. L. Boyd, N. Van De Velde, D. R. Green, and A. M. Jonathan, “PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology,” PLoS Pathogens, vol. 6, no. 7, Article ID e1001014, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Krug, Unique Functions of the NS1 Protein, Textbook of Inffuenza Blackwell Science, Oxford, UK, 1998.
  69. O. P. Zhirnov and H. D. Klenk, “Influenza a virus proteins NS1 and hemagglutinin along with M2 are involved in stimulation of autophagy in infected cells,” Journal of Virology, vol. 87, no. 24, pp. 13107–13114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. O. P. Zhirnov, T. E. Konakova, T. Wolff, and H.-D. Klenk, “NS1 protein of influenza A virus down-regulates apoptosis,” Journal of Virology, vol. 76, no. 4, pp. 1617–1625, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. O. P. Zhirnov and H.-D. Klenk, “Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling,” Apoptosis, vol. 12, no. 8, pp. 1419–1432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Hatada, S. Saito, and R. Fukuda, “Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells,” Journal of Virology, vol. 73, no. 3, pp. 2425–2433, 1999. View at Google Scholar · View at Scopus
  73. Y. Lu, M. Wambach, M. G. Katze, and R. M. Krug, “Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor,” Virology, vol. 214, no. 1, pp. 222–228, 1995. View at Publisher · View at Google Scholar · View at Scopus
  74. S.-L. Tan and M. G. Katze, “Biochemical and genetic evidence for complex formation between the influenza a virus NS1 protein and the interferon-induced PKR protein kinase,” Journal of Interferon & Cytokine Research, vol. 18, no. 9, pp. 757–766, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Ludwig, X. Wang, C. Ehrhardt et al., “The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors,” Journal of Virology, vol. 76, no. 21, pp. 11166–11171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. S. J. Morris, K. Nightingale, H. Smith, and C. Sweet, “Influenza A virus-induced apoptosis is a multifactorial process: exploiting reverse genetics to elucidate the role of influenza A virus proteins in virus-induced apoptosis,” Virology, vol. 335, no. 2, pp. 198–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Schultz-Cherry and V. S. Hinshaw, “Influenza virus neuraminidase activates latent transforming growth factor beta,” Journal of Virology, vol. 70, no. 12, pp. 8624–8629, 1996. View at Google Scholar · View at Scopus
  78. T. Daidoji, T. Koma, A. Du et al., “H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells,” Journal of Virology, vol. 82, no. 22, pp. 11294–11307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Gannagé, D. Dormann, R. Albrecht et al., “Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes,” Cell Host and Microbe, vol. 6, no. 4, pp. 367–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Shintani and D. J. Klionsky, “Autophagy in health and disease: a double-edged sword,” Science, vol. 306, no. 5698, pp. 990–995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Chen, M. J. Hong, H. Sun et al., “Essential role for autophagy in the maintenance of immunological memory against influenza infection,” Nature Medicine, vol. 20, no. 5, pp. 503–510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Schlie, A. Westerback, L. DeVorkin et al., “Survival of effector CD8+ T cells during influenza infection is dependent on autophagy,” Journal of Immunology, vol. 194, no. 9, pp. 4277–4286, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Liu, S. Xiong, Y.-F. Xiang et al., “Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus,” Archives of Virology, vol. 156, no. 8, pp. 1359–1369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Liu, M. Zhong, C. Guo et al., “Autophagy is involved in regulating influenza A virus RNA and protein synthesis associated with both modulation of Hsp90 induction and mTOR/p70S6K signaling pathway,” The International Journal of Biochemistry & Cell Biology, vol. 72, pp. 100–108, 2016. View at Publisher · View at Google Scholar
  85. P. Matarrese, L. Nencioni, P. Checconi et al., “Pepstatin A alters host cell autophagic machinery and leads to a decrease in influenza A virus production,” Journal of Cellular Physiology, vol. 226, no. 12, pp. 3368–3377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J.-P. Dai, W.-Z. Li, X.-F. Zhao et al., “A drug screening method based on the autophagy pathway and studies of the mechanism of evodiamine against influenza A virus,” PLoS ONE, vol. 7, no. 8, Article ID e42706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Dai, G. Wang, W. Li et al., “High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy,” Journal of Biomolecular Screening, vol. 17, no. 5, pp. 605–617, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. Yan, Z. Zou, Y. Sun et al., “Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model,” Cell Research, vol. 23, no. 2, pp. 300–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. J.-P. Dai, X.-F. Zhao, J. Zeng et al., “Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using bifc technique and mechanism of eugenol on anti-influenza A virus activity,” PLoS ONE, vol. 8, no. 4, Article ID e61026, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. H.-Y. Zhu, L. Han, X.-L. Shi et al., “Baicalin inhibits autophagy induced by influenza A virus H3N2,” Antiviral Research, vol. 113, pp. 62–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Yeganeh, S. Ghavami, A. L. Kroeker et al., “Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 308, no. 3, pp. L270–L286, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. A. H.-Y. Law, D. C.-W. Lee, K.-Y. Yuen, M. Peiris, and A. S.-Y. Lau, “Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction,” Cellular and Molecular Immunology, vol. 7, no. 4, pp. 263–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Kawai and S. Akira, “Innate immune recognition of viral infection,” Nature Immunology, vol. 7, no. 2, pp. 131–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. C.-S. Shi and J. H. Kehrl, “MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages,” The Journal of Biological Chemistry, vol. 283, no. 48, pp. 33175–33182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Pan, Y. Zhang, Z. Luo et al., “Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-κB and p38 MAPK signaling pathways,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 306, no. 2, pp. L183–L195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Chang, S. V. Kuchipudi, K. H. Mellits et al., “Early apoptosis of porcine alveolar macrophages limits avian influenza virus replication and pro-inflammatory dysregulation,” Scientific Reports, vol. 5, Article ID 17999, 2015. View at Publisher · View at Google Scholar
  97. R. Weiss, J. Laengle, M. Sachet et al., “Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis,” Antiviral Research, vol. 123, pp. 93–104, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Everett and G. McFadden, “Apoptosis: an innate immune response to virus infection,” Trends in Microbiology, vol. 7, no. 4, pp. 160–165, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. J. L. McAuley and J. A. McCullers, “Pro-inflammatory effects of H5N1 and 20th century pandemic influenza virus PB1-F2 proteins are mediated by macrophages,” Influenza and other Respiratory Viruses, vol. 5, pp. 280–283, 2011. View at Google Scholar
  100. D. Zamarin, A. García-Sastre, X. Xiao, R. Wang, and P. Palese, “Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1,” PLoS Pathogens, vol. 1, no. 1, article e4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. G.-W. Chen, C.-C. Yang, K.-C. Tsao et al., “Influenza A virus PB1-F2 gene in recent taiwanese isolates,” Emerging Infectious Diseases, vol. 10, no. 4, pp. 630–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Yoshizumi, T. Ichinohe, O. Sasaki et al., “Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity,” Nature Communications, vol. 5, article 4713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. L. A. Perrone, J. K. Plowden, A. García-Sastre, J. M. Katz, and T. M. Tumpey, “H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice,” PLoS Pathogens, vol. 4, no. 8, Article ID e1000115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. C. R. Baskin, H. Bielefeldt-Ohmann, T. M. Tumpey et al., “Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 9, pp. 3455–3460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. M. D. de Jong, C. P. Simmons, T. T. Thanh et al., “Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia,” Nature Medicine, vol. 12, no. 10, pp. 1203–1207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. J. L. McAuley, M. D. Tate, C. J. MacKenzie-Kludas et al., “Activation of the NLRP3 inflammasome by IAV Virulence protein PB1-F2 contributes to severe pathophysiology and disease,” PLoS Pathogens, vol. 9, no. 5, Article ID e1003392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. A. L. Reis and J. W. McCauley, “The influenza virus protein PB1-F2 interacts with IKKβ and modulates NF-κB signalling,” PLoS ONE, vol. 8, no. 5, article e63852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Chevalier, A. Al Bazzal, J. Vidic et al., “PB1-F2 influenza A virus protein adopts a β-sheet conformation and forms amyloid fibers in membrane environments,” The Journal of Biological Chemistry, vol. 285, no. 17, pp. 13233–13243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. T. A. Timofeeva, H. D. Klenk, and O. P. Zhirnov, “Identification of the protease-binding domain in the N-terminal region of influenza virus A matrix protein M1,” Molecular Biology, vol. 35, no. 3, pp. 411–416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. O. P. Zhirnov, A. L. Ksenofontov, S. G. Kuzmina, and H. D. Klenk, “Interaction of influenza A virus M1 matrix protein with caspases,” Biochemistry, vol. 67, no. 5, pp. 534–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. S. J. Morris, G. E. Price, J. M. Barnett, S. A. Hiscox, H. Smith, and C. Sweet, “Role of neuraminidase in influenza virus-induced apoptosis,” Journal of General Virology, vol. 80, no. 1, pp. 137–146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Tripathi, J. Batra, W. Cao et al., “Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein clusterin,” Cell Death and Disease, vol. 4, no. 3, article e562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. H. Ying, T. Z. Zaks, R.-F. Wang et al., “Cancer therapy using a self-replicating RNA vaccine,” Nature Medicine, vol. 5, no. 7, pp. 823–827, 1999. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Balachandran, C. N. Kim, W.-C. Yeh, T. W. Mak, K. Bhalla, and G. N. Barber, “Activation of the dsRNAdependent protein kinase, PKR, induces apoptosis through FADDmediated death signaling,” The EMBO Journal, vol. 17, no. 23, pp. 6888–6902, 1998. View at Publisher · View at Google Scholar · View at Scopus
  115. K. Uetani, S. D. Der, M. Zamanian-Daryoush et al., “Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase,” The Journal of Immunology, vol. 165, no. 2, pp. 988–996, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. H. Kato, O. Takeuchi, S. Sato et al., “Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses,” Nature, vol. 441, no. 1, pp. 101–105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. W. J. Wurzer, C. Ehrhardt, S. Pleschka et al., “NF-κB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation,” The Journal of Biological Chemistry, vol. 279, no. 30, pp. 30931–30937, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. S. Herold, M. Steinmueller, W. von Wulffen et al., “Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand,” The Journal of Experimental Medicine, vol. 205, no. 13, pp. 3065–3077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. B. Liu, D. Meng, T. Wei, S. Zhang, Y. Hu, and M. Wang, “Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses,” PLoS ONE, vol. 9, no. 6, Article ID e100109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  120. J. Jaworska, F. Coulombe, J. Downey et al., “NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 20, pp. E2110–E2119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. A. T. Tran, M. N. Rahim, C. Ranadheera et al., “Knockdown of specific host factors protects against influenza virus-induced cell death,” Cell Death and Disease, vol. 4, no. 8, article e769, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. K. Kosai, M. Seki, A. Tanaka et al., “Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection,” Japanese Journal of Infectious Diseases, vol. 64, no. 6, pp. 451–457, 2011. View at Google Scholar · View at Scopus
  123. M. C. Abt, L. C. Osborne, L. A. Monticelli et al., “Commensal bacteria calibrate the activation threshold of innate antiviral immunity,” Immunity, vol. 37, no. 1, pp. 158–170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. T. Ichinohe, I. K. Pang, Y. Kumamoto et al., “Microbiota regulates immune defense against respiratory tract influenza A virus infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 13, pp. 5354–5359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Wang, F. Li, R. Sun et al., “Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages,” Nature Communications, vol. 4, article 2106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. A. I. Wolf, M. C. Strauman, K. Mozdzanowska et al., “Pneumolysin expression by Streptococcus pneumoniae protects colonized mice from influenza virus-induced disease,” Virology, vol. 462-463, no. 1, pp. 254–265, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Miettinen, S. Matikainen, J. Vuopio-Varkila et al., “Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells,” Infection and Immunity, vol. 66, no. 12, pp. 6058–6062, 1998. View at Google Scholar · View at Scopus
  128. M. Nakamatsu, N. Yamamoto, M. Hatta et al., “Role of interferon-γ in Vα14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs,” Microbes and Infection, vol. 9, no. 3, pp. 364–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. U. Koppe, K. Högner, J.-M. Doehn et al., “Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs,” Journal of Immunology, vol. 188, no. 2, pp. 811–817, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. T. L. McCool, T. R. Cate, G. Moy, and J. N. Weiser, “The immune response to pneumococcal proteins during experimental human carriage,” The Journal of Experimental Medicine, vol. 195, no. 3, pp. 359–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. E. A. Joyce, S. J. Popper, and S. Falkow, “Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression,” BMC Genomics, vol. 10, article 404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  132. X. G. Guo, S. Zhou, and Y. Xia, “Autophagy is a defense mechanism in the infection of lung epithelial celss for streptococcus pneumonia,” in Respirology, p. 165, Wiley-Blackwell, Hoboken, NJ, USA, 2013. View at Google Scholar
  133. Y. Xu, C. Jagannath, X.-D. Liu, A. Sharafkhaneh, K. E. Kolodziejska, and N. T. Eissa, “Toll-like receptor 4 is a sensor for autophagy associated with innate immunity,” Immunity, vol. 27, no. 1, pp. 135–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Amano, I. Nakagawa, and T. Yoshimori, “Autophagy in innate immunity against intracellular bacteria,” Journal of Biochemistry, vol. 140, no. 2, pp. 161–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. P. Li, J. Shi, Q. He et al., “Streptococcus pneumoniae induces autophagy through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS hypergeneration in A549 cells,” PLoS ONE, vol. 10, no. 3, Article ID e0122753, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. K. Ouyang, S. A. Woodiga, V. Dwivedi et al., “Pretreatment of epithelial cells with live Streptococcus pneumoniae has no detectable effect on influenza A virus replication In vitro,” PLoS ONE, vol. 9, Article ID e90066, 2014. View at Publisher · View at Google Scholar
  137. L. Fang, H.-M. Wu, P.-S. Ding, and R.-Y. Liu, “TLR2 mediates phagocytosis and autophagy through JNK signaling pathway in Staphylococcus aureus-stimulated RAW264.7 cells,” Cellular Signalling, vol. 26, no. 4, pp. 806–814, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. I. Christopoulou, K. Roose, L. I. Ibañez, and X. Saelens, “Influenza vaccines to control influenza-associated bacterial infection: where do we stand?” Expert Review of Vaccines, vol. 14, no. 1, pp. 55–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. B. Michiels, K. van Puyenbroeck, V. Verhoeven, E. Vermeire, and S. Coenen, “The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews,” PLoS ONE, vol. 8, no. 4, Article ID e60348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. J. J. Treanor, F. G. Hayden, P. S. Vrooman et al., “Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial,” Journal of the American Medical Association, vol. 283, no. 8, pp. 1016–1024, 2000. View at Publisher · View at Google Scholar · View at Scopus
  141. J. A. McCullers, “Influenza,” in Textbook of Clinical Pediatrics, pp. 1199–1208, 2012. View at Google Scholar
  142. F. Carrat and A. Flahault, “Influenza vaccine: the challenge of antigenic drift,” Vaccine, vol. 25, no. 39-40, pp. 6852–6862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. H. W. Boucher and G. R. Corey, “Epidemiology of methicillin-resistant Staphylococcus aureus,” Clinical Infectious Diseases, vol. 46, no. 5, pp. S344–S349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. B. K. Giersing, S. S. Dastgheyb, K. Modjarrad, and V. Moorthy, “Status of vaccine research and development of vaccines for Staphylococcus aureus,” Vaccine, 2016. View at Publisher · View at Google Scholar
  145. D. R. Hahn, C.-L. Na, and T. E. Weaver, “Reserve autophagic capacity in alveolar epithelia provides a replicative niche for influenza A virus,” American Journal of Respiratory Cell and Molecular Biology, vol. 51, no. 3, pp. 400–412, 2014. View at Publisher · View at Google Scholar · View at Scopus